Tsuji T - Search Results

1

Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients.

Hosoya K, Ozasa H, Tanji M, Yoshida H, Ajimizu H, Tsuji T, Yoshida H, Terada Y, Sano N, Mineharu Y, Miyamoto S, Hirai T, Arakawa Y. Hosoya K, et al. Among authors: tsuji t. BMC Cancer. 2024 Aug 21;24(1):1030. doi: 10.1186/s12885-024-12798-2. BMC Cancer. 2024. PMID: 39169327 Free PMC article.

2

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.

Nomizo T, Ozasa H, Tsuji T, Funazo T, Yasuda Y, Yoshida H, Yagi Y, Sakamori Y, Nagai H, Hirai T, Kim YH. Nomizo T, et al. Among authors: tsuji t. Sci Rep. 2017 Mar 23;7:45124. doi: 10.1038/srep45124. Sci Rep. 2017. PMID: 28332580 Free PMC article.

3

Efficacy of Ceritinib After Alectinib for ALK-positive Non-small Cell Lung Cancer.

Yoshida H, Kim YH, Ozasa H, Sakamori Y, Tsuji T, Nomizo T, Yasuda Y, Yamamoto T, Ajimizu H, Hirai T. Yoshida H, et al. Among authors: tsuji t. In Vivo. 2018 Nov-Dec;32(6):1587-1590. doi: 10.21873/invivo.11418. In Vivo. 2018. PMID: 30348720 Free PMC article.

4

Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab.

Funazo TY, Nomizo T, Ozasa H, Tsuji T, Yasuda Y, Yoshida H, Sakamori Y, Nagai H, Hirai T, Kim YH. Funazo TY, et al. Among authors: tsuji t. Sci Rep. 2019 Nov 19;9(1):17085. doi: 10.1038/s41598-019-53327-7. Sci Rep. 2019. PMID: 31745135 Free PMC article.

5

PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade.

Yoshida H, Nomizo T, Ozasa H, Tsuji T, Funazo T, Yasuda Y, Ajimizu H, Yamazoe M, Kuninaga K, Ogimoto T, Hosoya K, Itotani R, Sakamori Y, Kim YH, Hirai T. Yoshida H, et al. Among authors: tsuji t. Eur J Cancer. 2021 Feb;144:317-325. doi: 10.1016/j.ejca.2020.11.035. Epub 2020 Dec 30. Eur J Cancer. 2021. PMID: 33385948

6

Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.

Ajimizu H, Ozasa H, Sato S, Funazo T, Sakamori Y, Nomizo T, Kuninaga K, Ogimoto T, Hosoya K, Yamazoe M, Tsuji T, Yoshida H, Itotani R, Ueno K, Kim YH, Muro S, Hirai T. Ajimizu H, et al. Among authors: tsuji t. Sci Rep. 2021 Dec 8;11(1):23677. doi: 10.1038/s41598-021-03139-5. Sci Rep. 2021. PMID: 34880386 Free PMC article.

7

Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer.

Yamazoe M, Ozasa H, Tsuji T, Funazo T, Yoshida H, Hashimoto K, Hosoya K, Ogimoto T, Ajimizu H, Yoshida H, Itotani R, Sakamori Y, Kuninaga K, Aoki W, Hirai T. Yamazoe M, et al. Among authors: tsuji t. Cancer Sci. 2023 Feb;114(2):546-560. doi: 10.1111/cas.15622. Epub 2022 Nov 23. Cancer Sci. 2023. PMID: 36285485 Free PMC article.

8

Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung Cancer.

Ogimoto T, Ozasa H, Tsuji T, Funazo T, Yamazoe M, Hashimoto K, Yoshida H, Hosoya K, Ajimizu H, Nomizo T, Yoshida H, Hamaji M, Menju T, Yoshizawa A, Date H, Hirai T. Ogimoto T, et al. Among authors: tsuji t. Mol Cancer Ther. 2024 Apr 2;23(4):564-576. doi: 10.1158/1535-7163.MCT-23-0371. Mol Cancer Ther. 2024. PMID: 38052760

9

EGFR T790M Detection in Circulating Tumor DNA from Non-small Cell Lung Cancer Patients Using the PNA-LNA Clamp Method.

Yoshida H, Kim YH, Ozasa H, Nagai H, Sakamori Y, Tsuji T, Nomizo T, Funazo T, Yasuda Y, Hirai T. Yoshida H, et al. Among authors: tsuji t. Anticancer Res. 2017 May;37(5):2721-2725. doi: 10.21873/anticanres.11623. Anticancer Res. 2017. PMID: 28476851

10

Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer.

Tsuji T, Sakamori Y, Ozasa H, Yagi Y, Ajimizu H, Yasuda Y, Funazo T, Nomizo T, Yoshida H, Nagai H, Maeno K, Oguri T, Hirai T, Kim YH. Tsuji T, et al. Oncotarget. 2017 May 16;8(42):71805-71816. doi: 10.18632/oncotarget.17895. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069748 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,759 results

Search Page

Filters